How to Get Prometrium in New Hampshire

What Is Prometrium and Why Is It Prescribed

Prometrium is the brand name for FDA-approved oral micronized progesterone, indicated to protect the uterine lining in postmenopausal women receiving estrogen therapy and to treat secondary amenorrhea. The FDA approved the 100 mg capsule formulation in 1998. Unlike synthetic progestins such as medroxyprogesterone acetate (MPA), micronized progesterone is chemically identical to the progesterone produced by the corpus luteum.

The Clinical Case for Micronized Progesterone Over Synthetic Progestins

The Postmenopausal Estrogen/Progestin Interventions trial (PEPI, N=875, published in JAMA 1995) found that women taking conjugated equine estrogen plus micronized progesterone had significantly better HDL-cholesterol profiles compared with women taking conjugated equine estrogen plus MPA. [1] The PEPI findings shaped subsequent prescribing norms for postmenopausal hormone therapy.

A 2019 analysis in Climacteric (Stute et al.) reported that micronized progesterone does not appear to carry the same venous thromboembolism signal associated with certain synthetic progestins, though the absolute risk difference remains modest and individual risk assessment is still required. [2]

FDA Label Indications

The Prometrium prescribing label lists two approved indications: (1) prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women receiving conjugated estrogens 0.625 mg, and (2) secondary amenorrhea. [3] Off-label use in perimenopausal women for sleep support and cycle regulation is common in clinical practice, though the evidence base for those uses is thinner.

The Endocrine Society's 2022 clinical practice guideline on menopause states: "Micronized progesterone is preferred over synthetic progestins when the primary goal is endometrial protection with a favorable metabolic and tolerability profile." [4]

New Hampshire Telehealth Laws and Prometrium Prescribing

New Hampshire permits telehealth prescribing of non-controlled medications, including Prometrium, provided the clinician establishes a valid patient-provider relationship before issuing a prescription. That relationship may be formed through a synchronous audio-video visit.

What NH Telehealth Law Requires

New Hampshire RSA 329:1-d defines a telehealth encounter as one that uses real-time interactive audio-video technology. A clinician may not prescribe based solely on an asynchronous questionnaire for a new patient; at least one synchronous visit is required for the initial prescription. [5] After that initial visit, asynchronous follow-up may be sufficient for refills at the clinician's discretion.

NH-licensed physicians, nurse practitioners operating under independent authority (NH RSA 326-B), and physician assistants working under a collaborative practice agreement may all write a Prometrium prescription after a qualifying telehealth encounter.

Telehealth Platforms Serving New Hampshire

Several national and regional telehealth platforms hold NH prescriber licenses and offer HRT consultations. When evaluating a platform, confirm that:

• The prescribing clinician holds an active NH license (searchable via the NH Office of Professional Licensure and Certification)
• The platform can send a prescription to an NH-licensed retail or mail-order pharmacy
• Labs can be ordered through a national draw network with a site in your area (e.g., Labcorp or Quest Diagnostics, both of which operate NH patient service centers)

Most platforms complete the initial consultation within 24 to 72 hours of scheduling. [6]

Labs Required Before a Prometrium Prescription in New Hampshire

No clinician should prescribe Prometrium without a baseline hormonal and metabolic workup. The standard panel before initiating progesterone as part of HRT includes specific blood tests that rule out contraindications and establish a hormone baseline.

Standard Pre-Treatment Lab Panel

A typical pre-Prometrium lab order will include:

• Serum estradiol (E2)
• Follicle-stimulating hormone (FSH) and luteinizing hormone (LH)
• Comprehensive metabolic panel (CMP), to check liver function since progesterone is hepatically metabolized
• Complete blood count (CBC)
• Thyroid-stimulating hormone (TSH), to exclude thyroid dysfunction as a cause of menstrual irregularity
• Lipid panel, given the mild impact of progestogens on HDL

For perimenopausal patients, a serum progesterone drawn on day 21 of the cycle can confirm whether ovulation is occurring, which affects the clinical rationale for supplementation.

Imaging Considerations

The North American Menopause Society recommends that women with a uterus who are initiating estrogen therapy also discuss baseline transvaginal ultrasound to measure endometrial thickness. [7] An endometrial stripe above 4 mm in a postmenopausal woman may warrant biopsy before starting estrogen-progestogen combination therapy.

Prometrium is protective against endometrial hyperplasia precisely because progesterone promotes the secretory transformation and eventual shedding of proliferative endometrium. A 2020 Cochrane review on progestogens for preventing endometrial hyperplasia in postmenopausal women confirmed that cyclical progestogens at adequate doses reduce hyperplasia risk to under 1% over 12 months compared with estrogen-alone rates exceeding 20%. [8]

Who Can Prescribe Prometrium in New Hampshire

Physicians (MD and DO)

Any MD or DO holding an active NH medical license may prescribe Prometrium after establishing a valid clinical relationship. Gynecologists and internists with a menopause subspecialty are the most common prescribers. The American College of Obstetricians and Gynecologists (ACOG) recommends that clinicians managing HRT be familiar with the 2022 Menopause Society guidelines on progestogen selection. [9]

Nurse Practitioners

New Hampshire grants full practice authority to advanced practice registered nurses (APRNs). An APRN with prescriptive authority does not require a physician collaborator to prescribe Prometrium. [10] This makes NH-based NPs an accessible option for telehealth HRT consultations.

Physician Assistants

PAs in New Hampshire may prescribe Prometrium under a written collaborative agreement with a supervising physician. The PA's prescriptive authority scope must explicitly include hormonal medications. Most PA collaborative agreements in HRT-focused telehealth practices include progesterone preparations by default.

New Hampshire Pharmacy Access: Retail, Mail-Order, and 503A Compounding

Brand-Name Prometrium at NH Retail Pharmacies

Prometrium 100 mg and 200 mg capsules are stocked at most major NH retail chains, including CVS, Walgreens, and Hannaford pharmacies. GoodRx pricing for 30 capsules of 200 mg Prometrium in NH ZIP codes ranges from approximately $38 to $65 depending on the pharmacy, as of mid-2025. The brand carries a significantly higher cash price, reaching $250 or more per 30-count, making generic micronized progesterone (available since 2016) the standard dispensed product in most cases.

Mail-Order Options

Mail-order pharmacies such as Amazon Pharmacy, Costco Pharmacy, and specialty HRT-focused pharmacies ship to NH addresses. Standard ground shipping from a mail-order pharmacy to an NH address typically takes 2 to 5 business days. Most telehealth platforms send e-prescriptions directly to the patient's preferred pharmacy within hours of the consultation.

503A Compounding Pharmacies in New Hampshire

503A pharmacies are state-licensed compounding pharmacies operating under the USP 795 and 797 standards. New Hampshire licenses several 503A compounding pharmacies that may prepare micronized progesterone in customized doses or delivery forms (e.g., suppositories, topical preparations) when a clinician documents a medical necessity for compounding over commercially available Prometrium.

The FDA's guidance on compounding notes that 503A pharmacies may compound micronized progesterone for individual patients based on a valid prescription and a documented clinical reason. [11] Compounding is not simply a lower-cost substitute for FDA-approved Prometrium; it requires a specific clinical justification.

The table below outlines when a clinician may direct a patient toward compounded micronized progesterone versus FDA-approved Prometrium:

| Clinical Situation | Appropriate Product | |---|---| | Standard endometrial protection, 100 mg or 200 mg oral dose | FDA-approved Prometrium (generic or brand) | | Peanut allergy (Prometrium capsules contain peanut oil) | Compounded micronized progesterone in alternative base | | Need for vaginal suppository form | Compounded 100 mg or 200 mg vaginal suppository | | Need for transdermal progesterone (though evidence for endometrial protection is limited) | 503A compounded cream, with clinician documentation | | Dose outside 100 mg / 200 mg commercially available | 503A compounded to specific dose |

Note for patients with peanut allergy: Prometrium capsules are manufactured in a peanut oil base. Patients with known peanut allergy should not take the brand-name or generic Prometrium capsule and must use a compounded alternative prepared in a non-allergenic base. The FDA label for Prometrium explicitly lists peanut oil as an ingredient. [3]

NH Medicaid and Insurance Coverage for Prometrium

Medicaid

New Hampshire Medicaid (Granite Advantage Health Care Program) does not include Prometrium or generic micronized progesterone on its preferred drug list for the indication of endometrial protection on HRT as of 2025. Patients on Medicaid who require Prometrium for this indication must typically pay out of pocket or pursue a prior authorization (PA) process.

Commercial Insurance Prior Authorization

Many commercial insurers covering NH residents require prior authorization before covering brand-name Prometrium, even when generic micronized progesterone is available. A PA request for Prometrium typically requires:

1. Documentation that the patient has a uterus and is receiving estrogen therapy
2. Serum lab results confirming menopausal or perimenopausal status (FSH >40 mIU/mL in postmenopausal context)
3. A statement of medical necessity from the prescribing clinician
4. Attestation that the patient has tried generic micronized progesterone (step therapy) if the insurer requires it

The turnaround for a standard PA in NH commercial plans is typically 3 to 5 business days. Urgent PA requests can be resolved within 24 to 72 hours when a clinician provides documentation of clinical urgency.

A 2021 study in JAMA Internal Medicine found that prior authorization requirements for hormonal therapies increased patient abandonment rates by 28% at the pharmacy counter, underscoring the need for clinicians to submit PA requests proactively rather than waiting for a rejection. [12]

Manufacturer Assistance

AbbVie offers a savings card for commercially insured patients that can reduce the out-of-pocket cost of brand-name Prometrium to as low as $0 per month for eligible patients. Patients on government insurance programs are not eligible. The savings card is available through AbbVie's patient assistance portal.

Step-by-Step: Getting Your Prometrium Prescription in New Hampshire

Getting Prometrium in NH follows a predictable sequence regardless of whether you use a telehealth platform or an in-person clinic.

Step 1. Choose a Provider Type

Decide between an in-person gynecologist or primary care physician and a telehealth platform. In-person visits typically take longer to schedule (2 to 6 weeks for a new patient appointment at most NH gynecology practices), while telehealth consultations are often available within 24 to 48 hours.

Step 2. Complete Pre-Visit Labs

Order labs before your consultation when possible. Many telehealth platforms allow you to request a lab order slip before the visit so results are available during the appointment. Labcorp has 18 patient service centers in New Hampshire; Quest Diagnostics operates 11 draw sites. [6]

Step 3. Attend the Synchronous Visit

The prescribing clinician will review your labs, take a full medical and obstetric history, discuss contraindications (including undiagnosed vaginal bleeding, known or suspected breast cancer, active DVT, liver dysfunction, and peanut allergy), and determine the appropriate Prometrium dose and regimen.

Step 4. Receive and Fill the Prescription

The e-prescription goes to your selected pharmacy. Most retail NH pharmacies fill Prometrium same-day. Mail-order delivery averages 2 to 5 business days. 503A compounded preparations typically require 3 to 7 business days for preparation and shipping.

Step 5. Follow-Up at 8 to 12 Weeks

A follow-up visit 8 to 12 weeks after initiation allows the clinician to assess tolerability, confirm appropriate cycle response (or absence of irregular bleeding), and repeat any labs that were borderline at baseline. The Endocrine Society recommends annual reassessment of HRT regimens, with dose adjustments based on symptom control and evolving cardiovascular and breast cancer risk calculations. [4]

Safety, Contraindications, and Drug Interactions

Absolute Contraindications

Prometrium is contraindicated in patients with:

• Undiagnosed abnormal uterine bleeding
• Known or suspected pregnancy
• Known or suspected breast cancer or other progestogen-sensitive cancers
• Active deep vein thrombosis, pulmonary embolism, or a history of these conditions
• Active arterial thromboembolic disease (e.g., recent MI or stroke)
• Liver dysfunction or disease
• Known hypersensitivity to micronized progesterone or peanut oil

Common Side Effects

Drowsiness is the most frequently reported side effect of oral micronized progesterone, which is why the standard dosing instruction is "take at bedtime." In clinical trials supporting the FDA approval, dizziness was reported in 15% of patients taking Prometrium 200 mg vs. 9% on placebo, and headache in 16% vs. 8%. [3] These CNS effects reflect progesterone's action on GABA-A receptors via its neuroactive metabolite allopregnanolone.

Drug Interactions

Prometrium is a substrate of CYP3A4. Co-administration with strong CYP3A4 inducers (rifampin, carbamazepine, phenytoin) may reduce plasma progesterone concentrations. Strong CYP3A4 inhibitors (ketoconazole, clarithromycin, ritonavir) may increase progesterone exposure and could amplify sedative effects. A 2018 review in the British Journal of Clinical Pharmacology confirmed that the CYP3A4 interaction is clinically meaningful at standard Prometrium doses. [13]

Monitoring While on Prometrium

Patients taking Prometrium as part of HRT should report any of the following promptly:

• Breakthrough or unexpected vaginal bleeding
• Breast pain or new breast mass
• Leg swelling or pain suggesting DVT
• Visual disturbances
• Severe headache or migraine change in pattern

Annual mammography and pelvic exams remain the standard of care for women on combined estrogen-progestogen therapy, consistent with ACOG guidelines. [9]

Dosing Regimens Used in New Hampshire Clinical Practice

Continuous Combined Regimen

100 mg of oral micronized progesterone nightly, combined with daily estrogen. This regimen produces amenorrhea in most postmenopausal women after 3 to 6 months and is preferred by women who do not want scheduled withdrawal bleeds. The PEPI trial used this regimen in one arm and demonstrated adequate endometrial protection. [1]

Sequential (Cyclical) Regimen

200 mg orally at bedtime for 12 consecutive days per calendar month, combined with daily estrogen. This produces a predictable withdrawal bleed at the end of each 12-day course. The FDA-approved label specifically supports the 200 mg for 12 days regimen. [3]

Perimenopausal Use

Some NH clinicians use Prometrium 100 mg nightly during the luteal phase (days 14 to 28) in perimenopausal women with irregular cycles and progesterone insufficiency confirmed by a day-21 serum progesterone below 5 ng/mL. This is off-label but consistent with emerging practice guidelines from the Menopause Society. [7]